Butyric Acid → HCID 178454556, compound

HRID 1909382Notes

Reaction equation

HRID 1909382 reaction equation
Cl.[O:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]3[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][C@H:19]4[CH2:24][CH2:23][C@H:22]([NH2:25])[CH2:21][CH2:20]4)[CH2:13][CH2:12]3)[C:5]=2[O:4][CH2:3]1.[C:26](O)(=[O:30])[CH2:27][CH2:28][CH3:29]>>[O:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]3[CH2:16][CH2:15][N:14]([CH2:17][CH2:18][C@H:19]4[CH2:20][CH2:21][C@H:22]([NH:25][C:26](=[O:30])[CH2:27][CH2:28][CH3:29])[CH2:23][CH2:24]4)[CH2:13][CH2:12]3)[C:5]=2[O:4][CH2:3]1

Participants

3

Reactant 2

HCID 264Butyric AcidHCID 178479251HCID 178479251, compound2×

Product 1

HCID 178454556HCID 178454556, compound

Procedure

The title compound, light yellow solid (12.9 mg, 46%), MS (ISP) m/z=401.4[(M+H)+], was prepared in accordance with the general method of example 1 from Trans-4-[2-(4-Benzo[1,3]dioxol-4-yl-piperidin-1-yl)-ethyl]-cyclohexylamine hydrochloride (intermediate A) (25.7 mg, 0.07 mmol) and butyric acid

Sources & evidence

ORD record
ord-73e9479ca0e240a3936de39d55018028
Source dataset
uspto-grants-2013_12
Patent number
US08598357B2

Reaction notes

Loading…